OncoLink en espanõl
Share
Types of Cancer > Brain Tumors > News
November 2009
Tumor pattern after treatment failure predicts glioblastoma prognosis
October 2009
Anticonvulsants thought to inhibit chemotherapy actually prolong glioblastoma survival
Bevacizumab safe, effective in phase II glioblastoma study
Patients with "limited number of brain metastases" advised to forego whole brain radiation
August 2009
Cognitive deficits seen with radiotherapy for low-grade glioma
July 2009
Network of altered genes linked to gliomas
June 2009
Cognitive rehabilitation program benefits patients with gliomas
April 2009
Adding bevacizumab improves chemotherapy for recurrent glioma
Methylation status helps guide glioma therapy
Salvage therapy with bevacizumab slows progression of high-grade glioma
Drug boost plus radiotherapy promising in glioblastoma
March 2009
MGMT methylation predicts glioblastoma response to temozolomide plus RT
January 2009
Elderly glioblastoma patients may be undertreated
TP53 gene variant linked to early-onset glioblastoma
Postsurgical radiotherapy delay not harmful in glioblastoma
November 2008
Erlotinib does not improve survival in glioblastoma multiforme
Chemoradiotherapy feasible in breast cancer with brain metastases
Cilengitide promising against recurrent glioblastoma multiforme
September 2008
Stereotactic radiosurgery improves survival in older patients with brain metastases
Relatives of patients with brain tumors seen to be at increased risk
July 2008
Brain tumors diagnosed in first year of life linked to later complications
Immune and clinical responses seen with glioblastoma vaccination
June 2008
Stereotactic radiosurgery can extend survival in small recurrent glioblastomas
Bevacizumab and irinotecan active against high-grade recurrent gliomas
May 2008
Sen. Edward Kennedy has brain tumor, hospital says
Transporter inhibition reduces glioma-related brain edema
April 2008
Perfusion MRI can predict progression of gliomas
Cediranib shows promise for recurrent glioblastoma
Alternating electric fields shrink recurrent glioblastoma tumors
March 2008
Neuroimaging and genomics characterize glioblastoma non-invasively
MR perfusion imaging predicts malignant transformation of gliomas
February 2008
Combination of implants benefits patients with recurrent glioblastoma
January 2008
Tri-molecular route promising in glioblastoma multiforme
REFILE: Prenatal radiography does not increase risk of childhood brain tumors
December 2007
Prenatal radiography does not increase risk of childhood brain tumors
MR angiography detects vascular changes during treatment for brain metastases
November 2007
Bevacizumab plus irinotecan prolongs survival in recurrent glioblastoma
Atopy linked to lower risk of glioma
August 2007
Prophylactic cranial irradiation reduces brain metastases from extensive lung cancer
May 2007
Integrin inhibitor induces response in recurring malignant glioma
Stereotactic radiosurgery improves survival after melanoma brain metastases
April 2007
Radiation therapy provides modest benefit to elderly patients with glioblastoma
Geminin expression tied to favorable brain tumor outlook
March 2007
Mobile phone use unrelated to increased glioma risk
Bevacizumab slows progression of malignant glioma
February 2007
Statin plus cyclopamine blocks medulloblastoma
January 2007
Brain tumor stem cells lurk in perivascular niches
Tyrosine kinase inhibitor shows promise against recurrent glioblastoma
December 2006
Large number of younger siblings may raise brain tumor risk
Bone morphogenetic proteins block glioblastoma growth in mice
Childhood leukemia, brain tumor survivors at risk for stroke
November 2006
Engineered vesicular stomatitis virus kills malignant glioma in mice
October 2006
Vitamins in pregnancy may cut brain tumor risk in offspring
August 2006
Functional MRI allows more aggressive brain tumor treatment
Stem cell-like glioma cells promote tumor angiogenesis
L-type amino acid transporter 1 plays key role in human gliomas
Paternal heat exposure may raise risk of childhood brain tumor
June 2006
Brain tumor patients seem capable and motivated to exercise
May 2006
Cholesterol inhibitors block proliferation of medulloblastoma cells
hTERT expression points to prognosis of pediatric brain tumors
April 2006
Fluorescence-guided surgery improves glioma survival
Vaccine curbs glioblastoma tumor growth, extends survival
Donepezil improves cognition in brain tumor patients
March 2006
Carmustine implant improves malignant glioma survival
Scottish health spending watchdog rejects Temodal for glioblastoma multiforme
Prolonged lymphopenia common with long-term temozolomide for glioma
January 2006
Clustering of glioma cases suggests an infectious etiology
Efaproxiral a promising adjunct to radiotherapy for brain metastases
Long-term survival possible after radiosurgery for brain metastases
Oncolytic virus works with alkylating agent to destroy glioma cells
December 2005
Radiotherapy for low-grade glioma can restore cognitive function
November 2005
Molecular markers identify glioblastomas sensitive to EGFR kinase inhibitors
October 2005
Treatment with nucleotides and radiation effective in glioma model
September 2005
Early radiotherapy delays progression of low-grade brain tumors
Quality of life impaired for children with brain tumors
August 2005
Combined gene therapy effective against glioma in rats
July 2005
Gene therapy for brain tumors shows promise in animals
Asthma-related polymorphisms inversely linked to glioblastoma multiforme
Targeting resistance-associated protein aids brain tumor chemotherapy
June 2005
Biomarkers predict erlotinib response in glioma
April 2005
EMP3 may be neuroblastoma and glioma suppressor gene
Levetiracetam may reduce seizures caused by brain tumors
Hormonal factors not strongly tied to brain tumors in women
March 2005
Temozolomide may prolong survival in glioblastoma patients
Postop chemotherapy may replace radiation for pediatric medulloblastoma
February 2005
Herstatin blocks experimental glioblastoma growth
Chemotherapy often avoided in treatment of malignant glioma
December 2004
Immune-mediated gene therapy ups survival glioblastoma model
November 2004
White matter lesions following medulloblastoma therapy can mimic recurrence
Investigational brain tumor drug results encouraging in phase I trial
Antitumor vaccination safely improves prognosis of glioblastoma
Cancer stem cells seen in human brain tumors
Blood volume-focused MRI helps identify brain tumors
September 2004
DNA repair gene tied to temozolomide response in glioblastoma
Small-molecule Sonic Hedgehog blocker clears medulloblastoma in mice
Outlook better after total resection of malignant gliomas in children
August 2004
Cannabinoids block brain tumor angiogenesis via VEGF pathway
Fluorescence spectroscopy images brain tumors
PIK3CA oncogene tied to brain tumors
Vaccine plus chemotherapy prolongs survival of patients with glioblastoma
July 2004
Immunotherapy strategy shows promise as treatment for glioma
Paternal polycyclic hydrocarbon exposure boosts brain tumor risk in offspring
June 2004
NSAIDs might just protect against brain tumors
Temozolomide plus radiotherapy ups survival in glioblastoma multiforme
Brain tumor irradiation tied to osteopenia in children
April 2004
Pegylated liposomal doxorubicin promising for recurrent high-grade glioma
March 2004
Greater brain tumor resection experience leads to improved outcomes
Candidate brain tumor gene identified
January 2004
Microspheres deliver 5-FU to inoperable brain tumors
Gefitinib shows promise in recurrent glioblastoma
Salvage therapy is beneficial in patients with glioblastoma
December 2003
Permissive environment required for brain tumor formation
October 2003
Stereotactic radiotherapy effective for pediatric brain tumors
Inherited BRCA2 mutations linked to pediatric brain tumors
August 2003
New disease model may hold key to malignant glioma treatment
Balloon system safely delivers brachytherapy for glioma recurrence
July 2003
Marker predicts progression of pilocytic astrocytoma after resection
Thalidomide with carmustine active against brain tumors
May 2003
Modified adenovirus shows promise against glioma cells
April 2003
Reduced PAX6 expression predicts poor outcome in malignant astrocytic glioma
March 2003
Intratumoral dendritic cell vaccination prolongs survival in rat glioma
February 2003
Hypothyroidism a sequela of cranial irradiation of pediatric brain tumor
January 2003
Pediatric brain tumor treatment confers risk for later endocrine, cardiovascular problems
Recombinant neural stem cells track and destroy experimental glioma
December 2002
Radioiodinated antibody increases survival of patients with high-grade glioma
November 2002
Immunosuppressive drug boosts radiation for glioblastoma
October 2002
High-dose radiotherapy for glioma treatment can lead to cognitive impairment
Temozolomide plus cisplatin "interesting" for recurrent glioma
IL-12 secreting neural stem cells track and destroy murine glioma
Temozolomide improves response of brain metastases to radiation therapy
September 2002
Jimson weed extract induces differentiation of glioma cells
Targeted delivery of diphtheria toxin causes regression of experimental glioblastoma
Vaccine strain of measles virus causes regression of experimental glioblastoma
August 2002
Blocking calcium influx at glutamate receptors may inhibit glioblastoma spread
July 2002
Intrathecal methotrexate worsens cognitive function in children treated for medulloblastoma
June 2002
Activating ion channels increases drug delivery to brain tumors
Allergies may protect against glioma
April 2002
Toxin-fusion protein targets glioblastoma in animal model
Brain tumors safely removed on outpatient basis
March 2002
Chemotherapy modestly improves survival in glioma patients
February 2002
Viral protein found in medulloblastoma cells
December 2001
Intratumoral IL-12 gene transfer shows promise as glioma immunotherapy
November 2001
Organ transplant recipients be at increased risk of gliomas
October 2001
Assay of DNA repair defects may identify patients at risk of glioma
September 2001
Genetics of medulloblastoma metastasis may provide therapeutic target
August 2001
NMDA receptor antagonists may retard growth of some malignant gliomas
MRI provides best diagnostic strategy for brain tumor in high-risk children
July 2001
Awake patients are helpful during brain tumor resection
Varicella-zoster virus antibodies inversely associated with glioblastoma
May 2001
Engineered polio virus destroys malignant glioma cells in animal model
Women with primary brain tumors are at increased risk for divorce
April 2001
Photodynamic therapy for gliomas shows safety in phase II trial
February 2001
New dendritic cell vaccine elicits beneficial immune response in glioma patients
January 2001
Australian oncologists will treat pediatric brain tumors with novel radiation therapy
November 2000
Guilford's Gliadel improves survival, outcome in malignant glioma patients
September 2000
Stereotactic radiosurgery effective for some brain metastases
Radiosurgery effective for brain metastases of unknown origin
August 2000
Physician's suit claims cell phone use caused brain tumor
July 2000
Compound targeting alpha-tubulin is active against breast and brain tumor cells
Complement depletion facilitates oncolytic HSV infection of rat brain tumors
June 2000
Herpes simplex virus mutants may benefit patients with malignant glioma
Tumor-specific monoclonal antibodies may effectively treat brain tumors
Interleukin-13-receptor-alpha is specific brain tumor marker
May 2000
Allos' investigational drug for brain metastases awarded fast-track status by FDA
Activated Ras and Akt tyrosine kinases cooperate to induce glioblastomas in mice
March 2000
Neural progenitor cells used to deliver interleukin-4 to glioblastomas
January 2000
Interferon gene therapy has anti-angiogenic effect on brain tumors in mice
July 1999
FDA approves CyberKnife radiation device for brain tumors
Additional evidence suggests that epilepsy increases the risk of brain tumor
Genetic defect predisposes ALL patients to radiation-associated brain tumors
June 1999
Spontaneous regression of glioma possible in children with neurofibromatosis-1
May 1999
Boron neutron capture therapy safe in patients with glioblastoma multiforme
Temozolomide prolongs progression-free survival in patient with glioblastoma multiforme
April 1999
Alkermes discontinues phase III study of brain tumor drug
February 1999
Celgene, NCI to study thalidomide in glioblastoma treatment
Dendritic cell vaccines being tested on astrocytomas
January 1999